Syngen Biotech Co.,Ltd. (TPEX:8279)

Syngen Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	341.93	366.89	246.05	314.8	423.42
Cash & Short-Term Investments	341.93	366.89	246.05	314.8	423.42
Cash Growth	-6.80%	49.11%	-21.84%	-25.65%	-18.48%
Accounts Receivable	422.56	387.8	472.06	388.16	298.71
Other Receivables	0	0	0	0	-
Receivables	422.56	387.8	472.06	388.16	298.71
Inventory	345.62	348.99	369.35	291.96	259.78
Prepaid Expenses	44.93	28.77	25.42	23.17	34.92
Total Current Assets	1,155	1,132	1,113	1,018	1,017
Property, Plant & Equipment	1,518	1,526	1,543	1,035	1,035
Long-Term Investments	324.34	331.74	313.75	293.55	2.7
Other Intangible Assets	27.57	24.13	22.96	23.42	27.32
Long-Term Deferred Tax Assets	18.86	17.44	16.21	12.32	10.39
Other Long-Term Assets	38.4	73.21	58.7	28.23	28.94
Total Assets	3,085	3,106	3,071	2,416	2,127
Accounts Payable	255.87	226.47	248.45	236.86	140.59
Accrued Expenses	78.84	72.8	79.89	64.72	3.94
Short-Term Debt	-	80	230	-	50
Current Portion of Long-Term Debt	59.03	59.03	-	-	-
Current Portion of Leases	14.71	13.38	14.85	13.7	14.11
Current Income Taxes Payable	35.18	62.06	76.99	58.39	28.12
Current Unearned Revenue	24.83	20.04	6.73	6.55	1.97
Other Current Liabilities	51.7	50.81	62.56	38.4	73.27
Total Current Liabilities	520.16	584.58	719.47	418.61	312
Long-Term Debt	163.95	222.97	182	50	-
Long-Term Leases	160.25	163.1	173.93	172.39	186.17
Long-Term Deferred Tax Liabilities	4.17	3.98	3.93	3.16	2.58
Total Liabilities	848.52	974.63	1,079	644.16	500.74
Common Stock	271.01	271.01	271.01	271.01	271.01
Additional Paid-In Capital	618.24	618.2	618.06	612.83	610.54
Retained Earnings	1,344	1,243	1,103	887.88	744.67
Comprehensive Income & Other	2.73	-0.26	-0.07	-0.36	-0.12
Shareholders' Equity	2,236	2,132	1,992	1,771	1,626
Total Liabilities & Equity	3,085	3,106	3,071	2,416	2,127
Total Debt	397.93	538.49	600.78	236.08	250.28
Net Cash (Debt)	-56	-171.6	-354.73	78.72	173.14
Net Cash Growth	-	-	-	-54.53%	-52.69%
Net Cash Per Share	-2.06	-6.33	-13.07	2.90	6.38
Filing Date Shares Outstanding	27.1	27.1	27.1	27.1	27.1
Total Common Shares Outstanding	27.1	27.1	27.1	27.1	27.1
Working Capital	634.89	547.87	393.41	599.48	704.84
Book Value Per Share	82.51	78.66	73.49	65.36	60.00
Tangible Book Value	2,209	2,107	1,969	1,748	1,599
Tangible Book Value Per Share	81.49	77.76	72.64	64.50	58.99
Land	251	251	251	-	-
Buildings	729.7	717.09	702.28	532.98	529.5
Machinery	1,022	871.44	841.51	693.37	656.19
Construction In Progress	74.67	146.33	114.01	111.97	79.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.